Compare Franklin FTSE South Korea ETF (FLKR) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Franklin FTSE South Korea ETF vs State Street SPDR S&P Biotech ETF — how do they compare? Franklin FTSE South Korea ETF trades at $58.41 (market cap $1.83B), while State Street SPDR S&P Biotech ETF trades at $154 (market cap $10.11B). The key difference: State Street SPDR S&P Biotech ETF is far larger — about 5.5× Franklin FTSE South Korea ETF's market cap, and Franklin FTSE South Korea ETF is more actively traded (679,902 versus 12,903,266). Which is the better fit depends on your goals — on Pluang, investors hold Franklin FTSE South Korea ETF for 16 Days and State Street SPDR S&P Biotech ETF for 38 Days on average.
| FLKR | XBI | |
|---|---|---|
Market Cap | $1.83B | $10.11B |
Volume | 679,902 | 12,903,266 |
Sector | Broad Market / Factor | Broad Market / Factor |
52-Week High | $72.25 | $169.55 |
52-Week Low | $27.09 | $104.99 |
Typical Hold Time | 16 Days | 38 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XBI trades at $153.84, up 2.4% today, but technical indicators signal a bearish trend with resistance at $154. The ETF's modified equal-weight structure offers broad biotech exposure, benefiting from M&A activity and positive clinical catalysts, though key financial ratios are unavailable. Recent news highlights sector optimism driven by cancer vaccine breakthroughs and improved capital access.
Outlook is mixed: bullish sentiment from innovation and M&A supports growth potential, but high volatility and expense ratios relative to peers pose risks. Analyst consensus is neutral (100% Hold), suggesting cautious optimism amid technical bearishness.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Franklin FTSE South Korea ETF
Franklin FTSE South Korea ETF seeks to track an index of South Korean equities. The fund provides exposure to companies listed in South Korea across multiple sectors.
Read more on FLKR →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
